2,851
edits
Line 146: | Line 146: | ||
In the clinical study, a ~20-fold increase in bioavailability was measured compared to standard quercetin with equal doses. Given that Quercetin Phytosome contains ~40% and has a ~20 fold relative bioavailability, one can assume that the total bioavailability of standard quercetin is less than 2%. | In the clinical study, a ~20-fold increase in bioavailability was measured compared to standard quercetin with equal doses. Given that Quercetin Phytosome contains ~40% and has a ~20 fold relative bioavailability, one can assume that the total bioavailability of standard quercetin is less than 2%. | ||
Quercetin Phytosome overcomes the low bioavailability hurdle of quercetin and should help to fulfill the great health benefit potential of this flavonoid in the diet and as food supplements. | |||
==Clinical Applications and Effects on Longevity== | ==Clinical Applications and Effects on Longevity== |